These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28657848)
21. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices. Tanihata H; Minamiguchi H; Sato M; Kawai N; Sonomura T; Takasaka I; Nakai M; Sahara S; Nakata K; Shirai S Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1209-16. PubMed ID: 19688368 [TBL] [Abstract][Full Text] [Related]
22. Optimizing logistics for balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices by doing away with the indwelling balloon: concept and techniques. Saad WE; Nicholson DB Tech Vasc Interv Radiol; 2013 Jun; 16(2):152-7. PubMed ID: 23830672 [TBL] [Abstract][Full Text] [Related]
23. Can balloon-occluded retrograde transvenous obliteration be performed for gastric varices without gastrorenal shunts? Araki T; Hori M; Motosugi U; Sano K; Ishigame K; Nakajima H; Okada H; Araki T J Vasc Interv Radiol; 2010 May; 21(5):663-70. PubMed ID: 20430296 [TBL] [Abstract][Full Text] [Related]
24. BRTO assisted endoscopic Histoacryl injection in treating gastric varices with gastrorenal shunt. Wu Q; Jiang H; Linghu E; Zhang L; Wang W; Zhang J; He Z; Wang J; Yang Y; Sun G; Sun G Minim Invasive Ther Allied Technol; 2016 Dec; 25(6):337-344. PubMed ID: 27309571 [TBL] [Abstract][Full Text] [Related]
25. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. Ibukuro K; Sugihara T; Tanaka R; Fukuda H; Abe S; Tobe K; Tateishi R; Tagawa K J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712 [TBL] [Abstract][Full Text] [Related]
26. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation. Cho SK; Shin SW; Yoo EY; Do YS; Park KB; Choo SW; Han H; Choo IW Korean J Radiol; 2007; 8(6):520-30. PubMed ID: 18071283 [TBL] [Abstract][Full Text] [Related]
27. Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy. Choudhary NS; Baijal SS; Saigal S; Agarwal A; Saraf N; Khandelwal R; Jain V; Khandelwal AH; Kapoor A; Jain D; Misra SR; Puri R; Sud R; Soin AS J Clin Exp Hepatol; 2017 Dec; 7(4):300-304. PubMed ID: 29234193 [TBL] [Abstract][Full Text] [Related]
28. Improved Hepatic Reserve and Fibrosis in a Case of "Portal-Systemic Liver Failure" by Portosystemic Shunt Occlusion. Ishikawa T; Sasaki R; Nishimura T; Iwamoto T; Takami T; Yamasaki T; Sakaida I Am J Case Rep; 2020 Feb; 21():e921236. PubMed ID: 32063601 [TBL] [Abstract][Full Text] [Related]
29. Four-dimensional flow magnetic resonance imaging for assessment of hemodynamic changes in the portal venous system before and after balloon-occluded retrograde transvenous obliteration: a pilot feasibility study. Hamasaki M; Araki T; Tamada D; Morisaka H; Johno H; Aikawa Y; Onishi H Acta Radiol; 2023 Apr; 64(4):1462-1468. PubMed ID: 36325676 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir. Takakusagi S; Shimizu M; Yokoyama Y; Kizawa K; Marubashi K; Kosone T; Sato K; Kakizaki S; Takagi H; Uraoka T Clin J Gastroenterol; 2020 Dec; 13(6):1303-1309. PubMed ID: 32914297 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. Arai H; Abe T; Takagi H; Mori M World J Gastroenterol; 2006 Jun; 12(24):3866-73. PubMed ID: 16804972 [TBL] [Abstract][Full Text] [Related]
32. Balloon-occluded retrograde transvenous obliteration for treatment of portal hypertensive related varices. Stoleru G; Henry Z Curr Opin Gastroenterol; 2023 May; 39(3):140-145. PubMed ID: 36976877 [TBL] [Abstract][Full Text] [Related]
33. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices. Choi YS; Lee JH; Sinn DH; Song YB; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC J Clin Gastroenterol; 2008 Oct; 42(9):974-9. PubMed ID: 18528292 [TBL] [Abstract][Full Text] [Related]
34. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. Kumamoto M; Toyonaga A; Inoue H; Miyakoda K; Morita Y; Emori K; Sakamoto Y; Oho K; Sata M J Gastroenterol Hepatol; 2010 Jun; 25(6):1129-35. PubMed ID: 20594229 [TBL] [Abstract][Full Text] [Related]
35. Portopulmonary venous anastomosis in balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices. Kariya S; Komemushi A; Nakatani M; Yoshida R; Kono Y; Shiraishi T; Tanigawa N J Gastroenterol Hepatol; 2014; 29(7):1522-7. PubMed ID: 24650189 [TBL] [Abstract][Full Text] [Related]
36. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Saad WE; Wagner CC; Lippert A; Al-Osaimi A; Davies MG; Matsumoto AH; Angle JF; Caldwell S Am J Gastroenterol; 2013 Oct; 108(10):1612-9. PubMed ID: 23939627 [TBL] [Abstract][Full Text] [Related]
37. Management of gastric varices. Garcia-Pagán JC; Barrufet M; Cardenas A; Escorsell A Clin Gastroenterol Hepatol; 2014 Jun; 12(6):919-28.e1; quiz e51-2. PubMed ID: 23899955 [TBL] [Abstract][Full Text] [Related]
38. Respiratory effects of balloon occluded retrograde transvenous obliteration of gastric varices: a prospective controlled study. Arai H; Abe T; Takayama H; Toyoda M; Mori K; Ueno T; Takagi H; Shimoda R J Gastroenterol Hepatol; 2011 Sep; 26(9):1389-94. PubMed ID: 21443664 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of different coils for endovascular coiling for intractable hepatic encephalopathy caused by a portosystemic shunt. Ishikawa T; Imai M; Endo S; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T; Yoshida T Ann Palliat Med; 2022 Jun; 11(6):1954-1960. PubMed ID: 35073712 [TBL] [Abstract][Full Text] [Related]
40. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. Hong CH; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Hong HP; Shin JH J Gastroenterol Hepatol; 2009 Mar; 24(3):372-8. PubMed ID: 19032446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]